Trial Profile
A pharmacokinetic study investigating the effect of micafungin in healthy subjects and patients with severe hepatic dysfunction
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Dec 2015
Price :
$35
*
At a glance
- Drugs Micafungin (Primary)
- Indications Aspergillosis; Candidaemia; Candidiasis
- Focus Pharmacokinetics
- Sponsors Astellas Pharma
- 06 Dec 2015 New trial record